Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Kymera Therapeutics (KYMR) Preferred Shares Issued (2019 - 2020)

Historic Preferred Shares Issued for Kymera Therapeutics (KYMR) over the last 2 years, with Q2 2020 value amounting to -$19000.0.

  • Kymera Therapeutics' Preferred Shares Issued changed N/A to -$19000.0 in Q2 2020 from the same period last year, while for Dec 2020 it was $88.2 million, marking a year-over-year change of. This contributed to the annual value of $88.2 million for FY2020, which is 31628.19% up from last year.
  • Kymera Therapeutics' Preferred Shares Issued amounted to -$19000.0 in Q2 2020.
  • In the past 5 years, Kymera Therapeutics' Preferred Shares Issued registered a high of $88.2 million during Q1 2020, and its lowest value of -$19000.0 during Q2 2020.